Regio‐isomers are utilized to design innovative AIE luminogens (AIEgens) by regulating molecular aggregation behavior. However, relevant examples are limited, and the underlying mechanism is not fully understood. Herein, a regio‐isomer strategy is used to develop AIEgens by precisely regulating the intermolecular interactions in the solid state. Among the regio‐isomers it is investigated, ortho‐ isomer ( DCM‐O3‐O7 ) exhibits enhanced AIE‐activity than the para ‐ isomer ( DCM‐P6 ), and the size of the ortho ‐ substituents is crucial for the AIE performance. The underlying mechanism of the strategy is revealed using DFT calculations and single‐crystal analysis. Dual hydrogen bonds (C─H∙∙∙π and C─H∙∙∙N) are generated between the molecules, which contributes to form dimers, tetramers, and 1D supramolecular structures in the crystal. By restricting intramolecular motion and attenuating π – π interactions, solid‐state fluorescence is significantly enhanced. This strategy's effectiveness is validated using other donor–acceptor fluorophores, with DCM‐O6 and its analogues serving as efficient probes for bioimaging applications. Notably, DCM‐OM , which bears a morpholinyl instead of piperidinyl group, displayed strong lysosome‐targeting ability and photostability; DCM‐OP , incorporated by the hydrophilic quaternary ammonium group, exhibited wash‐free imaging and cell membrane‐targeting capabilities; and DCM‐O6 nanoparticles enabled high‐fidelity in vivo tumor imaging. Therefore, this strategy affords a general method for designing bright AIEgens.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: